Abstract:Background: Previously, long non-coding RNA (lncRNA) gene AP001469.3 was reported to participate in the construction of an immune-related lncRNA signature, which showed promising clinical predictive value in colorectal cancer (CRC) patients. However, the clinical and immunological significance and biological function of AP001469.3 in CRC remain unclear. In this study, we aim to explore the roles of AP001469.3 in CRC progression, thereby opening an avenue for CRC treatment. Methods: Our study collected data from The Cancer Genome Atlas (TCGA) database and investigated the role of AP001469.3 in CRC through bioinformatics analysis. Cell-type Identification By Estimating Relative Subsets Of known RNA Transcripts (CIBERSORT) and Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) methods evaluated the immune infiltration. The biological functions of AP001469.3 in CRC were validated by in vitro experiments. Gene set enrichment analysis (GSEA) was used to estimate the enrichment of functional pathways and gene signatures. Results: In this work, high expression of AP001469.3 was found in CRC and was positively associated with tumor-node-metastasis (TNM) stage in CRC. AP001469.3 expression had a strong relationship with microsatellite instability (MSI) in colon adenocarcinoma (COAD). Additionally, AP001469.3 expression was associated with StromalScore, ImmuneScore, ESTIMATEScore, immune cell infiltration (ICI) levels and immune checkpoint (ICP) genes expression in CRC. Subsequent results showed that immunotherapy could be more effective in CRC patients with low-AP001469.3 expression using the immunophenoscore (IPS). We confirmed that the transcript of AP001469.3 gene ENST00000430259 was highly expressed in CRC tissues and cell lines. In vitro experiments indicated that ENST00000430259 knockdown reduced the proliferation, migration and invasion of CRC cells. Finally, our GSEA results showed that the majority of the differentially enriched signaling pathways between the high- and low-AP001469.3 expression groups were immune-related. Conclusions: Taken together, our study demonstrates that lncRNA gene AP001469.3 is associated with immunological characteristics in CRC and promotes malignant progression of CRC. Moreover, AP001469.3 can be potentially used as an immunotherapeutic indicator and a therapeutic target for CRC patients.

Research on the Correlation Between AP-1 and Invasion and Metastasis in Human Colorectal Carcinoma

[Correlation Between the Activation of AP-1 Signal Transduction Pathway and Metastasis of Colorectal Carcinoma].

[Dual Role of Transcription Factor AP-2 in Carcinogenesis].

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

The relationship between ABI1 upregulation and clinicopathological features and prognosis of colorectal adenocarcinoma

The roles of lncRNA AP001469.3 in clinical implications, immune landscape and carcinogenesis of colorectal cancer

The potential of activator protein 1 (AP-1) in cancer targeted therapy

Meta-analysis of the Association Between APC Promoter Methylation and Colorectal Cancer

The role of DACT1 in colon cancer

Expression of Chemokine MCP-1 in Colorectal Carcinoma and its Relationship with the Infiltration of Immunocyte

Chromatin-associated APC Regulates Gene Expression in Collaboration with Canonical WNT Signaling and AP-1.

Prognostic and immunological role of adaptor related protein complex 3 subunit mu2 in colon cancer

The Protein Expression of PLAC1/CP1 Genes in Colorectal Carcinoma and Its Clinical Significance

Specific Mutations in APC , with Prognostic Implications in Metastatic Colorectal Cancer

Prognostic significance of apical lymph node metastasis in patients with node-positive rectal cancer.

The expression of ERAP1 is favorable for the prognosis and immunotherapy in colorectal cancer: a study based on the bioinformatic and immunohistochemical analysis

Correlation Between DCAMKL-1 Protein Expression and K-ras Gene Mutation in Colorectal Cancer

Deciphering the influence of AP1M2 in modulating hepatocellular carcinoma growth and Mobility through JNK/ErK signaling pathway control

T1 Mapping and Amide Proton Transfer Weighted Imaging for Predicting Lymph Node Metastasis in Patients with Rectal Cancer

The Correlation in Transcriptional Expression with Promoter Hypermethylation of AKAP12 Gene in Bladder Transitional Cell Carcinoma

BAP31 is Frequently Overexpressed in Patients with Primary Colorectal Cancer and Correlates with Better Prognosis